General Information of the Compound
| Compound ID |
CP0430019
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(2-(1-(2,4-dimethoxyphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)ethylsulfonyl)-N-(1-phenylethyl)piperidin-4-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H41N3O6S2
|
||||||||||||||||||
| Molecular Weight |
627.829
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(c(OC)c1)S(=O)(=O)N1C(CCS(=O)(=O)N2CCC(CC2)NC(C)c2ccccc2)CCc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H41N3O6S2/c1-24(25-9-5-4-6-10-25)33-27-17-20-34(21-18-27)42(36,37)22-19-28-14-13-26-11-7-8-12-30(26)35(28)43(38,39)32-16-15-29(40-2)23-31(32)41-3/h4-12,15-16,23-24,27-28,33H,13-14,17-22H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
XBCRFHORBHXYPU-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01839, Vasopressin V1a receptor
Protein ID: PT01840, Vasopressin V1b receptor
Protein ID: PT03188, Vasopressin V1b receptor